Home › Funds › D. E. Shaw & Co › DCPH
D. E. Shaw & Co position in DCPH
DECIPHERA PHARMACEUTICALS IN
Latest position (Q1 2024)506.38K sh
Reported value held$7.97M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 10.00K | $340.00K | New |
| Q4 2021 | 149.91K | $1.47M | Add |
| Q1 2022 | 63.89K | $592.00K | Reduce |
| Q2 2022 | 166.88K | $2.19M | Add |
| Q3 2022 | 790.41K | $14.62M | Add |
| Q4 2022 | 998.49K | $16.37M | Add |
| Q1 2023 | 790.79K | $12.22M | Reduce |
| Q2 2023 | 381.81K | $5.38M | Reduce |
| Q3 2023 | 316.96K | $4.03M | Reduce |
| Q4 2023 | 388.66K | $6.27M | Add |
| Q1 2024 | 506.38K | $7.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.